DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Transgene Biotek Ltd (TRABI) share price today?

Transgene Biotek Ltd (TRABI) is trading at ₹2.72 on the BSE, down 1.81% on the day. Source: DocStoX.

What is the market capitalisation of Transgene Biotek Ltd?

Transgene Biotek Ltd has a market capitalisation of approximately ₹20 crore.

Transgene Biotek Ltd

₹2.72▼ -0.05 (-1.81%)

TRABI·BSE·Healthcare Services

Market Cap

20.46 Cr

PE Ratio

—

Volume

44,464

Day High - Low

2.82 - 2.65

52W High-Low

4.05 - 1.83

₹2.72▼ -0.05 (-1.81%)

Market Cap20.46 Cr

PE Ratio—

Volume44,464

Day High - Low2.82 - 2.65

52W High-Low4.05 - 1.83

DocStoX Score

1.0/10

Poor

Fair Value

ROE

-17.90%

Weak

P/E

—

Debt / Equity

2.05

High

Industry

Healthcare Services

Healthcare Service Provider

Overall View

Poor

Price performance

Day₹2.65

₹2.82

52W₹1.83

₹4.05

DocStoX take

Held back by quality (0.0).

DocStoX score

Low confidence

1.0

/10

Poor

Quality

Weak

ROE -17.9%

Valuation

Fair

P/B 2.6× on assets (no earnings to value)

Growth

Flat

Revenue +4.3% 5Y CAGR

Risk

High risk

D/E 2.05

Momentum

Soft

40% of 52-week range

At a glance

Market Cap

₹20 Cr

52W High / Low

₹4 / ₹2

Dividend Yield

0.00%

Promoter Holding

23.64%

EPS (TTM)

₹-0.09

Book Value

₹1.11

Key highlights

High leverage — debt is 2.0× equity
Loss-making in some of the last 5 years

0 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare Services stocks · Healthcare Service Provider

Explore Transgene Biotek Ltd’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Transgene Biotek Ltd peers in Healthcare Services

Other Healthcare Services stocks on the NSE & BSE. See the full Healthcare Services sector list.

Related tools & concepts

Value Transgene Biotek Ltd with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing